DPP4 and heart failure: Because there remains clinical caution regarding DPP-4 inhibitor-induced heart failure [44, 45], further experimental and clinical research is required to elucidate the precise mechanisms by which DPP-4 inhibitors affect diastolic function and heart failure in patients with T2DM.